Structure Therapeutics elects Sharon Tetlow to board; Ted Love joins audit committee

Structure Therapeutics Inc.

Sharon Tetlow elected as Class I director for 3-year term with 117.2M votes for, 12.6M against.
Shareholders ratified Ernst & Young as independent auditor for FY2024 (129.9M for, 32k against).
Ted W. Love, M.D. appointed to Audit Committee effective June 25, 2024.
Audit Committee now consists of Sharon Tetlow, Eric Dobmeier, and Dr. Love.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.